 <h1>Ulipristal Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of ulipristal include:</b> menstruation. <b>Other side effects include:</b> intermenstrual bleeding.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to ulipristal: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, ulipristal may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking ulipristal:</p><p>
<i>More common</i>
</p><ul>
<li>Cramps</li>
<li>heavy bleeding</li>
<li>pain</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of ulipristal may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>headache</li>
<li>nausea</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Dizziness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blemishes on the skin</li>
<li>pimples</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ulipristal: oral tablet</i></p><h3>Genitourinary</h3><p>-Endometrial thickening (more than 16 mm) reverses when treatment is stopped and menstrual periods resume.  This condition should not be mistaken for endometrial hyperplasia as these changes are reversible after treatment cessation.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Amenorrhea (up to 80.8%), endometrial thickening (up to 15%), dysmenorrhea (up to 13%)</p>
<p><b>Common</b> (1% to 10%): Pelvic pain, uterine hemorrhage, ovarian cyst</p>
<p><b>Uncommon</b> (0.1% to 1%): Menorrhagia, menstrual disorder, vaginitis, premenstrual syndrome, metrorrhagia, vaginal/genital discharge, urinary incontinence, ruptured ovarian cyst </p>
<p><b>Rare</b> (less than 0.1%): Genital pruritus, dyspareunia, vulvovaginal pain, hypomenorrhea<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Hot flush (up to 24%)</p>
<p><b>Common</b> (1% to 10%): Breast tenderness/pain, vertigo, edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Hot flush, pyrexia, breast swelling/discomfort </p>
<p><b>Rare</b> (less than 0.1%): Thirst<sup>[Ref]</sup></p><h3>General</h3><p>-The most common adverse reactions (10% or more) reported were hot flush, headache, nausea, abdominal pain, and dysmenorrhea.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Acne, hyperhidrosis </p>
<p><b>Uncommon</b> (0.1% to 1%): Alopecia, dry skin, skin lesion, pruritus</p>
<p><b>Rare</b> (less than 0.1%): Urticaria<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Abdominal pain (up to 15%), nausea (up to 13%)</p>
<p><b>Common</b> (1% to 10%): Abdominal discomfort, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Diarrhea, dry mouth, dyspepsia, flatulence<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Influenza<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Blood cholesterol increased </p>
<p><b>Uncommon</b> (0.1% to 1%): Appetite disorders, blood triglycerides increased, weight increased<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myalgia, back pain, musculoskeletal pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Asthenia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 19%)</p>
<p><b>Common</b> (1% to 10%): Fatigue, dizziness</p>
<p><b>Uncommon</b> (0.1% to 1%): Somnolence, migraine, chills, malaise</p>
<p><b>Rare</b> (less than 0.1%): Tremor, disturbance in attention, dysgeusia, syncope<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Visual disturbance</p>
<p><b>Rare</b> (less than 0.1%): Abnormal sensation in eye, ocular hyperemia, photophobia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Mood disorders</p>
<p><b>Uncommon</b> (0.1% to 1%): Emotional disorder, anxiety, insomnia, hyperactivity disorder, libido changes</p>
<p><b>Rare</b> (less than 0.1%): Disorientation<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Epistaxis</p>
<p><b>Rare</b> (less than 0.1%): Dry throat<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. ella (ulipristal)." Afaxys Inc., Charleston, SC. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about ulipristal</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>511 Reviews</li>
<li>Drug class: progesterone receptor modulators</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Ulipristal &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>ella</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Birth Control</li>
<li>Emergency Contraception</li>
<li>Uterine Fibroids</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ulipristal: oral tablet</i></p><h3>Genitourinary</h3><p>-Endometrial thickening (more than 16 mm) reverses when treatment is stopped and menstrual periods resume.  This condition should not be mistaken for endometrial hyperplasia as these changes are reversible after treatment cessation.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Amenorrhea (up to 80.8%), endometrial thickening (up to 15%), dysmenorrhea (up to 13%)</p><p><b>Common</b> (1% to 10%): Pelvic pain, uterine hemorrhage, ovarian cyst</p><p><b>Uncommon</b> (0.1% to 1%): Menorrhagia, menstrual disorder, vaginitis, premenstrual syndrome, metrorrhagia, vaginal/genital discharge, urinary incontinence, ruptured ovarian cyst </p><p><b>Rare</b> (less than 0.1%): Genital pruritus, dyspareunia, vulvovaginal pain, hypomenorrhea<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Hot flush (up to 24%)</p><p><b>Common</b> (1% to 10%): Breast tenderness/pain, vertigo, edema</p><p><b>Uncommon</b> (0.1% to 1%): Hot flush, pyrexia, breast swelling/discomfort </p><p><b>Rare</b> (less than 0.1%): Thirst<sup>[Ref]</sup></p><h3>General</h3><p>-The most common adverse reactions (10% or more) reported were hot flush, headache, nausea, abdominal pain, and dysmenorrhea.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Acne, hyperhidrosis </p><p><b>Uncommon</b> (0.1% to 1%): Alopecia, dry skin, skin lesion, pruritus</p><p><b>Rare</b> (less than 0.1%): Urticaria<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Abdominal pain (up to 15%), nausea (up to 13%)</p><p><b>Common</b> (1% to 10%): Abdominal discomfort, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Diarrhea, dry mouth, dyspepsia, flatulence<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Influenza<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Blood cholesterol increased </p><p><b>Uncommon</b> (0.1% to 1%): Appetite disorders, blood triglycerides increased, weight increased<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myalgia, back pain, musculoskeletal pain</p><p><b>Uncommon</b> (0.1% to 1%): Asthenia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 19%)</p><p><b>Common</b> (1% to 10%): Fatigue, dizziness</p><p><b>Uncommon</b> (0.1% to 1%): Somnolence, migraine, chills, malaise</p><p><b>Rare</b> (less than 0.1%): Tremor, disturbance in attention, dysgeusia, syncope<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Visual disturbance</p><p><b>Rare</b> (less than 0.1%): Abnormal sensation in eye, ocular hyperemia, photophobia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Mood disorders</p><p><b>Uncommon</b> (0.1% to 1%): Emotional disorder, anxiety, insomnia, hyperactivity disorder, libido changes</p><p><b>Rare</b> (less than 0.1%): Disorientation<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Epistaxis</p><p><b>Rare</b> (less than 0.1%): Dry throat<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. ella (ulipristal)." Afaxys Inc., Charleston, SC. </p><h2>More about ulipristal</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>511 Reviews</li>
<li>Drug class: progesterone receptor modulators</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Ulipristal &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Birth Control</li>
<li>Emergency Contraception</li>
<li>Uterine Fibroids</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>